Corpus overview


Overview

MeSH Disease

Human Phenotype

Transmission

gender (1)


Seroprevalence

There are no seroprevalence terms in the subcorpus

    displaying 1 - 1 records in total 1
    records per page




    Chemoprophylaxis of COVID-19 with hydroxychloroquine: Astudy of health care workers attitude, adherence to regimeand side effects

    Authors: Debajyoti Bhattacharyya; Neeraj Raizada; Bharathnag Nagappa; Arvind Tomar; Prateek Maurya; Ashok Chaudhary; Mini George; Deepty Katiyal; Srishti Rajora; Nikky Singh

    doi:10.1101/2020.06.11.20126359 Date: 2020-06-12 Source: medRxiv

    Background: There are apprehensions amongst healthcare worker (HCWs) about COVID-19. The HCWs have been given hydroxychloroquine (HCQ) chemoprophylaxis for seven weeks as per Government of India guidelines. Objectives: To assess the apprehensions amongst HCWs about COVID-19 and to document accessibility, adherence and side effects related to HCQ prophylaxis in HCWs. Methods: A longitudinal follow up study was conducted in a tertiary care hospital. HCQ was given in the dose of 400 mg twice on day one, and then 400 mg weekly for seven weeks. 391 HCWs were interviewed using semi-structured questionnaire. Results: 62.2% HCWs expressed perceived danger posted by COVID-19 infection MESHD. Doctors (54%) showed least acceptance and paramedics (88%) showed highest acceptance to chemoprophylaxis. 17.5% participants developed at least one of the side effects to HCQ. Females TRANS and nursing profession were significantly associated with adverse effects. Common side effects were gastro-intestinal symptoms, headache MESHD headache HP and abnormal mood change HP. Most of these were mild, not requiring any intervention. Gender TRANS, professions and perceived threat of COVID-19 were significantly associated with acceptance and adherence to HCQ prophylaxis. Conclusion: Two thirds of HCWs had perceived danger due to COVID-19. Three fourth of the HCWs accepted chemoprophylaxis and four out of five who accepted had complete adherence to prophylaxis schedule. One out of five had developed at least one of side effects; however, most of these were mild not requiring any intervention.

The ZB MED preprint Viewer preVIEW includes all COVID-19 related preprints from medRxiv and bioRxiv, from ChemRxiv, from ResearchSquare, from arXiv and from Preprints.org and is updated on a daily basis (7am CET/CEST).

Sources


Annotations

All
None
MeSH Disease
Human Phenotype
Transmission
Seroprevalence


Export subcorpus as Endnote

This service is developed in the project nfdi4health task force covid-19 which is a part of nfdi4health.

nfdi4health is one of the funded consortia of the National Research Data Infrastructure programme of the DFG.